MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Experience with apomorphine infusion cartridge in France – evaluation of patient and healthcare team benefits

    M. Vérin, M. Demais (Rennes, France)

    Objective: To evaluate ‘real-world’ benefits for patients with Parkinson’s disease (PD) and impact on healthcare team practice of the introduction of apomorphine infusion (APO) cartridge…
  • 2022 International Congress

    Identification and clinical characterization of GBA variants in the Luxembourg Parkinson’s Study

    S. Pachchek, Z. Landoulsi, D. Reddy Bobbili, L. Pavelka, O. Terwindt, J. Torre, A K. Hauser, C. Schulte, E. Buena-Atienza, C. Gross, N. Casadei, R. Krüger, P. May (Belvaux, Luxembourg)

    Objective: Assess the entire set of variants in the glucocerebrosidase (GBA) gene by long-read sequencing in the Luxembourg Parkinson’s study (LuxPARK) and characterize genotype-phenotype correlations…
  • 2022 International Congress

    Coexistence of Parkinson’s Disease and Myasthenia Gravis: Disease Characteristics and Confusion

    Z. Mao, Q. Nie, Z. Li, Z. Xue (Wuhan, China)

    Objective: In order to alert clinicians to the possibility of the coexistence of the two diseases and optimize the management of both conditions. Background: Parkinson’s…
  • 2022 International Congress

    The effect of co-administration of opicapone on the pharmacokinetics of levodopa

    D. Kamiyama, N. Nishikawa, G. Oyama, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: Few studies have examined levodopa (LD) pharmacokinetics in combination with opicapone (OPC) in Japanese patients with Parkinson's disease (PD). Therefore, we investigated changes in…
  • 2022 International Congress

    The effect of rasagiline on nocturnal hypokinesia: the analysis of the Nocturnal Hypokinesia Questionnaire (NHQ)

    J. Sringean, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To identify the effect of rasagiline on nocturnal hypokinesia based on Nocturnal Hypokinesia Questionnaire (NHQ). Background: Nocturnal hypokinesia refers to the difficulty or the…
  • 2022 International Congress

    Scaling the Roche Digital Health Technology Platform to Assess Disease Severity and Progression in Individuals with Parkinson’s Disease

    W. Popp, K. Taylor, A. Bamdadian, L. Restelli, J. Schjodt-Eriksen, G. Pagano, H. Svoboda, A. Bonni, M. Lindemann (Basel, Switzerland)

    Objective: Here we present the development of a novel platform to deliver the Roche Parkinson’s Disease (PD) Mobile Application to researchers to actively measure motor…
  • 2022 International Congress

    Compound heterozygous PANK2 variants in two unrelated kindreds with atypical PKAN

    A. Saini, R. Mewara, B. Verma, V. Scaria, B. Bk, A. Srivastava, R. Rajan (New Delhi, India)

    Objective: To describe two unrelated individuals with progressive, late-onset Pantothenate kinase-associated neurodegeneration (PKAN) and a common missense variant in the PANK2 gene Background: Neurodegeneration with Brain-Iron Accumulation…
  • 2022 International Congress

    What research participants want to know: Feedback from participants in an observational study of Parkinson’s disease

    S. Lettenberger, S. Jensen-Roberts, E. Wagner, M. Pawlik, J. Soto, E. Hartman, P. Yang, E. Nnadika, C. Tarolli, R. Schneider, J. Adams, E. Dorsey, T. Myers (Rochester, USA)

    Objective: To compare participant feedback regarding clinical assessments, patient-reported outcomes (PROs), and digital technologies provided in individual research reports in an observational study of Parkinson’s…
  • 2022 International Congress

    Hyperkinetic movement disorder following Covid: A Temporal corelation or Coincidental ?

    GP. Burman (Hisar, India)

    Objective: Hypokinetic movement disorder and parkinsonian like picture has been well described in literature but hyperkinetic movements are extremely rare and less highlighted in global…
  • 2022 International Congress

    Quality of Life in African American and White Parkinson’s Disease Patients

    D. Hall, S. Anderson, G. Stebbins, L. Barnes, M. Bailey, L. Shulman (Chicago, USA)

    Objective: To determine the quality of life of African American (AA) and White patients with Parkinson’s disease (PD) at the Rush University Medical Center (RUMC)…
  • « Previous Page
  • 1
  • …
  • 783
  • 784
  • 785
  • 786
  • 787
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley